Vandromme J - Search Results

1

Menopausal hormone therapy and breast cancer risk.

Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C. Rozenberg S, et al. Among authors: vandromme j. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10. Best Pract Res Clin Endocrinol Metab. 2021. PMID: 34535397 Review.

2

Postmenopausal hormone therapy: risks and benefits.

Rozenberg S, Vandromme J, Antoine C. Rozenberg S, et al. Among authors: vandromme j. Nat Rev Endocrinol. 2013 Apr;9(4):216-27. doi: 10.1038/nrendo.2013.17. Epub 2013 Feb 19. Nat Rev Endocrinol. 2013. PMID: 23419265 Review.

3

Attitudes to the prescription of menopause hormone therapy for vasomotor symptoms and osteoporosis for patients of different ages: A survey of gynecologists in Belgium.

Rozenberg S, Vandromme J. Rozenberg S, et al. Among authors: vandromme j. Maturitas. 2019 Oct;128:60-63. doi: 10.1016/j.maturitas.2019.07.024. Epub 2019 Aug 5. Maturitas. 2019. PMID: 31561825

4

Menopause Hormone Therapy in the Management of Postmenopausal Osteoporosis.

Rozenberg S, Vandromme J, Revercez P, Valcarenghi M, Joris A. Rozenberg S, et al. Among authors: vandromme j. Cancer J. 2022 May-Jun 01;28(3):204-207. doi: 10.1097/PPO.0000000000000592. Cancer J. 2022. PMID: 35594468 Review.

5

[Menopausal hormone treatment in 2011].

Rozenberg S, Vandromme J, Antoine C. Rozenberg S, et al. Among authors: vandromme j. Rev Med Brux. 2011 Sep;32(4):239-42. Rev Med Brux. 2011. PMID: 22034751 Review. French.

6

Should we abstain from treating women with endometriosis using menopausal hormone therapy, for fear of an increased ovarian cancer risk?

Rozenberg S, Antoine C, Vandromme J, Fastrez M. Rozenberg S, et al. Among authors: vandromme j. Climacteric. 2015;18(4):448-52. doi: 10.3109/13697137.2015.1041905. Epub 2015 May 11. Climacteric. 2015. PMID: 25958744

7

Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey.

Plusquin C, Fastrez M, Vandromme J, Rozenberg S. Plusquin C, et al. Among authors: vandromme j. Maturitas. 2011 Dec;70(4):391-4. doi: 10.1016/j.maturitas.2011.09.007. Epub 2011 Oct 19. Maturitas. 2011. PMID: 22014472

8

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!

Rozenberg S, Revercez P, Fastrez M, Vandromme J, Bucella D. Rozenberg S, et al. Among authors: vandromme j. Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:300-302. doi: 10.1016/j.ejogrb.2020.06.064. Epub 2020 Jun 27. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32650189 Free PMC article.

9

[Compliance with hormone replacement therapy].

Rozenberg S, Vandromme J, Kroll M, Twagirayezu P, Vyankandondera J. Rozenberg S, et al. Among authors: vandromme j. Rev Med Brux. 1995 Jul-Aug;16(4):295-8. Rev Med Brux. 1995. PMID: 7481246 French.

10

Compliance to hormone replacement therapy.

Rozenberg S, Vandromme J, Kroll M, Pastijn A, Liebens F. Rozenberg S, et al. Among authors: vandromme j. Int J Fertil Menopausal Stud. 1995;40 Suppl 1:23-32. Int J Fertil Menopausal Stud. 1995. PMID: 7581586 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page